Pages with the fewest revisions

Showing below up to 50 results in range #401 to #450.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Wrist osteoarthritis‏‎ (1 revision)
  2. B48. The notion and statement of brain death. Medico-legal prerequisites.‏‎ (1 revision)
  3. A4. Benign adnexal masses; classification, diagnosis and therapy‏‎ (1 revision)
  4. 60. Thrombosis. Causes and consequences‏‎ (1 revision)
  5. 19. Epidemiology and prevention of diabetes‏‎ (1 revision)
  6. 41. Splanchnic circulation‏‎ (1 revision)
  7. Percutaneous nephrostomy‏‎ (1 revision)
  8. Graves disease‏‎ (1 revision)
  9. B6. Lichen planus‏‎ (1 revision)
  10. A7. Herpes simplex virus (HSV) infections of the skin‏‎ (1 revision)
  11. 19B. Herpes infection, postherpetic neuralgia‏‎ (1 revision)
  12. 10. Imaging of ischemic heart diseases and cardiac valve diseases.‏‎ (1 revision)
  13. 43. Etiology and pathogenesis of 1DM‏‎ (1 revision)
  14. 3. Differentiation of the mesoderm. Development of the serous membranes and the body cavities. Malformations‏‎ (1 revision)
  15. Photodermatoses‏‎ (1 revision)
  16. B9. Proximal and middle shaft humeral fractures.‏‎ (1 revision)
  17. 10B. Intracerebral haemorrhage (ICH)‏‎ (1 revision)
  18. 44. Etiology and pathogenesis of 2DM‏‎ (1 revision)
  19. 3. Significance of signal transduction mechanisms in the effects of drugs. Tachyphylaxis and tolerance to drugs‏‎ (1 revision)
  20. Porphyria‏‎ (1 revision)
  21. 69. Nitroimidazoles. RNA polymerase inhibitors‏‎ (1 revision)
  22. 20. Epidemiology and prevention of osteoporosis‏‎ (1 revision)
  23. 11. Linitis plastica and Krukenberg tumor‏‎ (1 revision)
  24. 45. Nuclear medicine examinations in gastroenterology.‏‎ (1 revision)
  25. 30. Optional and mandatory screening‏‎ (1 revision)
  26. Bullous pemphigoid‏‎ (1 revision)
  27. Acute sinusitis‏‎ (1 revision)
  28. 7. Health politics‏‎ (1 revision)
  29. 119. Health effects of ionizing and non-ionizing radiations‏‎ (1 revision)
  30. Caeruloplasmin‏‎ (1 revision)
  31. 72. Principles of exercise testing (spiro-ergometry). Anaerobic threshold and maximal oxygen‏‎ (1 revision)
  32. 21. RNA metabolism‏‎ (1 revision)
  33. 12. Health issues and disparities of people living with disabilities‏‎ (1 revision)
  34. 48. Microbial carcinogenesis. RNA and DNA viruses. Helicobacter pylori‏‎ (1 revision)
  35. Central nervous system tumour‏‎ (1 revision)
  36. Asplenism‏‎ (1 revision)
  37. 77. Metabolic acidosis. Causes, compensation, consequences‏‎ (1 revision)
  38. 22. IgA nephropathy, chronic glomerulonephritis. Glomerular lesions associated with systemic disorders (SLE, Henoch-Schönlein purpura, Wegener’s granulomatosis, amyloidosis)‏‎ (1 revision)
  39. 13. Acoustic tumours, noise induced hearing losses‏‎ (1 revision)
  40. 49. Mechanisms of vasoconstriction and vasodilatation‏‎ (1 revision)
  41. 33. Epinephrine and glucagon‏‎ (1 revision)
  42. Keratoacanthoma‏‎ (1 revision)
  43. 8. Differentiation and derivatives of the pharyngeal pouches and clefts. Malformations‏‎ (1 revision)
  44. 23. Cohort studies‏‎ (1 revision)
  45. 13. Laboratory analysis of plasma enzymes‏‎ (1 revision)
  46. 5. Innate immunity, pattern recognition‏‎ (1 revision)
  47. 34. Intravascular radiologic interventions II. Interventional radiologic treatment of bleeding, vasoocclusive techniques (embolization, sclerotisation).‏‎ (1 revision)
  48. Left ventricular non-compaction‏‎ (1 revision)
  49. B13. Nerve injuries of the hand. Immediate and delayed nerve repair.‏‎ (1 revision)
  50. 82. Pharmacogenetics, pharmacogenomics. Effects of age, diet and disease on drug action‏‎ (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)